The effect of peri-procedural short-term steroid therapy for preventing atrial arrhythmia in blanking period after catheter ablation of atrial fibrillatio
Not Applicable
Completed
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0000107
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1) Over 18 years old, first catheter ablation of atrial fibrillation
2) Transthoracic echocardiographically LA dimension <55mm
3) Paroxysmal atrial fibrillation and persistent atrial fibrillation
4) A patient who agreed the writtend informed consent
Exclusion Criteria
1) A patient who rejected the informed consent
2) currently steroid treatment
3) active inflammation
4) active gastric and duodenal ulcer
5) active viral hepatitis or elevated liver enzyme
6) concurrent life threathening disease; end stage renal disease, end stage heart failure
7) documented osteroporosis and osteroporotic fracture
8) prosthetic valve replacement or LA dimension > 55mm
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Atrial tachycardiarrhythmia over 30 seconed (atrial tachycardia, atrial flutter, and atrial fibrillation) on EKG (Holter, event recorder, 12 lead ECG, hand held device)
- Secondary Outcome Measures
Name Time Method Clinical events(admission, ER visit, antiarrhythmic drug restart, DC cardioversion)